Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-07 · accession 0001437749-24-034228 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-08 | 2024-11-07 | BKYI | Williams Cameron E. | Dir | A - Grant | $0.00 | +2,587 | 8,816 | +42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-07 | A | A | 2,587 | $0.00 | 8,816 | D | — | — | (F1) Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board meeting attendance fees |